Renin-angiotensin system responses of acute graded hemorrhage in dogs. 1987

M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer

The effect of acute hemorrhage on hemodynamics and the renin-angiotensin system (RAS) was studied in eight anesthetized dogs. Stepwise blood loss to 17 +/- 6.2 ml/kg within 9 to 33 min decreased cardiac output (CO) to 42.8% of control. Mean arterial blood pressure was decreased to 35%, peripheral vascular resistance (PVR) was 1.58-fold increased, plasma renin activity (PRA) and plasma renin concentration (PRC) were increased 3.6-fold and 4.3-fold, respectively, angiotensin I (A I) concentration in plasma was 3.7-fold increased, angiotensin II (A II) was 3.8-fold increased, and A I-degrading enzyme was strongly decreased. Angiotensinogen, A I-converting enzyme, and A II-degrading enzyme activities into blood circulation were not significantly changed. The minimal blood loss to activate the RAS was 3 ml/kg. The rate of plasma active renin (PRA and PRC) increase depended on the velocity of blood withdrawn. PRA was correlated inversely to CO. PVR correlated linearly to increased plasma angiotensin concentrations. The experiments conducted demonstrate the high sensitivity and prompt activation of RAS to blood loss and suggest that RAS is involved in the regulating mechanisms of hemodynamics during acute graded hemorrhage. The stimulation of RAS supports survival of grave blood loss.

UI MeSH Term Description Entries
D008297 Male Males
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
February 1979, The Journal of physiology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
February 1990, Hypertension (Dallas, Tex. : 1979),
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
February 1990, The American journal of physiology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
October 1975, The American journal of physiology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
February 1971, Canadian journal of physiology and pharmacology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
August 1982, Endocrinology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
January 1972, Surgical forum,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
November 1986, The American journal of physiology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
January 1982, Journal of cardiovascular pharmacology,
M L Michailov, and H Schad, and H Dahlheim, and I C Jacob, and H Brechtelsbauer
March 1994, The American journal of physiology,
Copied contents to your clipboard!